About
The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.
Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, and autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration. Learn more about specific applications.
News
µSHEAR Techonology Featured on Francis Collins's Blog
iPS cells have a ‘stickiness’ that allows them to adhere to surfaces inside the sorting chip with different strengths than other cells.
May, 2013
Adhesive Differences Enable Separation of Stem Cells to Advance Potential Therapies
Nature Methods paper shows a new label-free separation process yielding up to 99% purity.
April, 2013
Burnsed Receives NSF Graduate Fellowship, McKinlay Honorable Mention
Over the past 8 years & out of 16 eligible students, the McDevitt lab has had 11 awardees & 4 honorable mentions!
April, 2013
From 2D Biology to Engineered 3D Medical Solutions
McDevitt particiapting in advanced short course for graduate students and post docs in Slovania.
April, 2013
2013 High Risk, High Reward Research Symposium
NIH Common Fund Awardees invited, McDevitt will attend in November 2013.
April, 2013
